Posts by: Isaura Santos

Isaura Santos

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

June 16, 2015June 16, 2015

Proven BCG Vaccine For Tuberculosis and Bladder Cancer Could Reverse Type 1 Diabetes

News, Type 1 Diabetes News

A phase II clinical trial to assess the ability of a generic vaccine called bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes recently received United States Food and Drug Administration (FDA) approval. Denise ... Read more

June 4, 2015June 4, 2015

ForaCare And Bioexpert Introduce Universal Tone To Address The Needs Of Diabetic Patients With Visual Impairment

News

ForaCare Suisse AG, a Swiss company and Bioexpert SRL, a Romania-based firm recently presented a new medical device called Universal Tone™ that allows visually impaired patients to manage their glucose levels at the 41st National Congress of SRDNBM ... Read more

May 25, 2015July 7, 2015

Structured Transition From Pediatric To Adult Diabetes Care Improves Outcomes

News

Recent findings show that a structured protocol that includes a transition coordinator and a joint sessions provider is effective in maximizing compliance with follow-ups and decreasing diabetes-related anxiety while transitioning from pediatric to adult diabetes care. ... Read more

May 19, 2015May 19, 2015

CeQur Announces Publication Of Study Results On PaQ® Insulin Delivery Device To Reduce Barriers To Insulin Therapy

News, Type 2 Diabetes News

CeQur SA, recently announced that the outcomes from a clinical study that assessed the company’s PaQ® Insulin Delivery Device will be published in the Journal of Diabetes Science and Technology. The results reveal that switching to ... Read more

April 22, 2015April 22, 2015

Link Between Diabetes, Cancer, and Cardiovascular Disease Revealed in Recent Study

News

Researcher Tim Byers from the University of Colorado Cancer Center described in a major symposium at the American Association for Cancer Research (AACR) Annual Meeting 2015 results of a research study revealing the connection between diabetes, cancer ... Read more

April 14, 2015April 14, 2015

Independence Blue Cross and CareCam Offers App To Manage Diabetes and Asthma

News

Pennsylvania-based Independence Blue Cross recently announced it has begun offering the CareCam Health Systems’ (CareCam) chronic condition self-management app to patients to better help them proactively manage their health. The organization is offering ... Read more

April 7, 2015April 7, 2015

Merck Collaborates With ADA To Educate Diabetics About Increased Risk For Pneumococcal Pneumonia And Hepatitis B

News

Merck (MSD) recently announced a partnership with the American Diabetes Association (ADA) that aims to educate adults living with diabetes about their higher risk for serious health issues such as hepatitis B and pneumococcal pneumonia influenza ... Read more

March 26, 2015March 26, 2015

Expanding Medicaid Under ACA Allowed the Identification of 23% More Individuals With Previously Undiagnosed Diabetes

News, Type 2 Diabetes News

According to a recent study in the journal Diabetes Care, the states that are under the Affordable Care Act (ACA) and have expanded their Medicaid programs are detecting a higher number of ... Read more

March 24, 2015March 24, 2015

Study Reveals That Quantose IR(TM) Measures Insulin Sensitivity Better Than A1C Test For Pre-diabetes

News

Metabolon, Inc. recently announced the results from a study that included samples from ACT NOW, a long-term diabetes prevention assessment of pre-diabetic subjects. Analysis showed that its Quantose IR™ test noted alterations in insulin sensitivity much better than the ... Read more

March 19, 2015March 19, 2015

Generex Provides Update on Buccal Insulin Formulation Enhancement Project

News

Generex Biotechnology Corporation recently provided updates on the company’s proprietary Generex Oral-lyn™ technology, a buccal insulin spray product. As previously reported, Generex has engaged the Center for Molecular Design and Preformulations (CMDP) at the ... Read more